EUROBIOCONCEPT : revenue, balance sheet and financial ratios

EUROBIOCONCEPT is a French company founded 19 years ago, specialized in the sector Intermédiaires spécialisés dans le commerce d'autres produits spécifiques. Based in BONNEUIL-SUR-MARNE (94380), this company of category PME shows in 2022 a revenue of 5.1 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - EUROBIOCONCEPT (SIREN 493134167)
Indicator 2024 2023 2022 2021 2020 2019 2018 2017 2016
Revenue N/C N/C 5 092 157 € N/C N/C N/C N/C N/C 3 991 097 €
Net income 38 320 € 28 622 € 4 451 € 1 330 € -76 733 € 31 511 € 59 796 € -22 632 € 423 477 €
EBITDA N/C N/C -79 557 € N/C N/C N/C N/C N/C 697 595 €
Net margin N/C N/C 0.1% N/C N/C N/C N/C N/C 10.6%

Revenue and income statement

In 2024, EUROBIOCONCEPT generates positive net income of 38 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 423 k€ -> 38 k€.

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

38 320 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 13%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 47%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

13.166%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

46.773%

Asset age ratio (2024) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

12.7%

Solvency indicators evolution
EUROBIOCONCEPT

Sector positioning

Debt ratio
13.17 2024
2022
2023
2024
Q1: 0.0
Med: 5.8
Q3: 35.12
Average

In 2024, the debt ratio of EUROBIOCONCEPT (13.17) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
46.77% 2024
2022
2023
2024
Q1: 15.09%
Med: 44.33%
Q3: 67.75%
Good -13 pts over 3 years

In 2024, the financial autonomy of EUROBIOCONCEPT (46.8%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.

Repayment capacity
-5.07 years 2022
2022
Q1: 0.0 years
Med: 0.0 years
Q3: 1.34 years
Excellent

In 2022, the repayment capacity of EUROBIOCONCEPT (-5.07) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 272.59. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

272.594

Liquidity indicators evolution
EUROBIOCONCEPT

Sector positioning

Liquidity ratio
272.59 2024
2022
2023
2024
Q1: 144.96
Med: 248.4
Q3: 435.6
Good

In 2024, the liquidity ratio of EUROBIOCONCEPT (272.59) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.

Interest coverage
-7.53x 2022
2022
Q1: 0.0x
Med: 0.0x
Q3: 1.59x
Watch

In 2022, the interest coverage of EUROBIOCONCEPT (-7.5x) ranks in the bottom 25% of the sector. This ratio indicates how many times operating income covers interest expenses. Low coverage may indicate fragility to rate or income variations.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 624 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 269 days. The gap of 355 days means the company finances its customers for over a month before being paid relative to supplier payments. This weighs on cash flow.

Operating WCR (2024) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2024) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

624 j

Supplier credit (2024) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

269 j

Inventory turnover (2024) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
EUROBIOCONCEPT

Positioning of EUROBIOCONCEPT in its sector

Comparison with sector Intermédiaires spécialisés dans le commerce d'autres produits spécifiques

Valuation estimate

Based on 50 transactions of similar company sales (all years), the value of EUROBIOCONCEPT is estimated at 61 478 € (range 42 866€ - 211 017€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Medium reliability: estimate to be confirmed with in-depth analysis.

Estimated enterprise value 2024
50 tx
42k€ 61k€ 211k€
61 478 € Range: 42 866€ - 211 017€
NAF 5 all-time

Valuation method used

Net Income Multiple
38 320 € × 1.6x = 61 478 €
Range: 42 867€ - 211 018€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 50 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Intermédiaires spécialisés dans le commerce d'autres produits spécifiques)

Compare EUROBIOCONCEPT with other companies in the same sector:

Voir toutes les statistiques du secteur Intermédiaires spécialisés dans le commerce d'autres produits spécifiques

Frequently asked questions about EUROBIOCONCEPT

What is the revenue of EUROBIOCONCEPT ?

The revenue of EUROBIOCONCEPT in 2022 is 5.1 M€.

Is EUROBIOCONCEPT profitable?

Yes, EUROBIOCONCEPT generated a net profit of 38 k€ in 2024.

Where is the headquarters of EUROBIOCONCEPT ?

The headquarters of EUROBIOCONCEPT is located in BONNEUIL-SUR-MARNE (94380), in the department Val-de-Marne.

Where to find the tax return of EUROBIOCONCEPT ?

The tax return of EUROBIOCONCEPT is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does EUROBIOCONCEPT operate?

EUROBIOCONCEPT operates in the sector Intermédiaires spécialisés dans le commerce d'autres produits spécifiques (NAF code 46.18Z). See the 'Sector positioning' section above to compare the company with its competitors.